CONAGRA BRANDS INC (CAG)       36.26  -0.65 (-1.76%)

36.26  -0.65 (-1.76%)

US2058871029 - Common Stock - After market: 36.25 -0.01 (-0.03%)


Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAG. CAG was compared to 105 industry peers in the Food Products industry. Both the profitability and financial health of CAG have multiple concerns. CAG is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

2

CAG has a Profit Margin of 5.66%. This is comparable to the industry average of 5.66%.
CAG has a Piotroski-F score of 6.00. This indicates an average health and profitability for CAG.

CAG's Return On Assets of 3.04% is worse than the rest of the industry. The industry average Return On Assets is 6.01%. 82% of the industry peers have a better Return On Assets.
CAG has a Return On Equity of 7.87%. This is below the industry average of 14.51%.
VS Industry

ROA (3.04%) VS Industry: 18% outperformed.

0.13
26.84

ROE (7.87%) VS Industry: 24% outperformed.

0.23
82.65

Profit Margin (5.66%) VS Industry: 51% outperformed.

0.08
41.73

Valuation

Valuation Rating

4

Compared to an average industry Price/Earning Ratio of 22.05, CAG is valued a bit cheaper than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of CAG to the average industry ratio of 14.31, CAG is valued rather cheaply.
The Price/Earnings Ratio is 13.89, which indicates a correct valuation of CAG.
With a Forward Price/Earnings Ratio of 13.73, CAG is valued correctly.

When comparing the current price to the book value of CAG, we can conclude it is valued correctly. It is trading at 1.99 times its book value.
When comparing the price book ratio of CAG to the average industry price book ratio of 1.87, CAG is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry

Price/Earnings (13.89) VS Industry: 75% outperformed.

549.00
5.40

Price/Book (1.99) VS Industry: 46% outperformed.

272.78
0.03

Enterprise Value/ EBITDA (12.27) VS Industry: 63% outperformed.

675.52
0.89

Growth

Growth Rating

4

The Earnings Per Share has grown by an nice 14.98% over the past year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, CAG shows a small growth in Earnings Per Share. The EPS has been growing by 3.98% on average per year.
The Earnings Per Share is expected to grow by 8.26% on average over the next 5 years.

CAG shows a small growth in Revenue. In the last year, the Revenue has grown by 7.29%.
CAG shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 8.07% yearly.
The Revenue is expected to grow by 3.07% on average over the next 5 years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS3.98% 5.65% 14.98% 4.6% 5.56% 5.75% 8.26%
Revenue8.07% 6.54% 7.29% 5.49% 3.43% 2.71% 3.07%

Health

Health Rating

3

An Altman-Z score of 1.96 indicates that CAG is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.21.
The Piotroski-F score of CAG is 6.00. This is a neutral score and indicates average health and profitability for CAG.
CAG has a Current Ratio of 0.92. This is a bad value and indicates that CAG is not financially healthy enough and could expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 1.80, CAG is worse placed to pay its short term obligations than its industry peers. 83% of its industry peers have a better Current Ratio.
CAG has a Quick Ratio of 0.92. This is a bad value and indicates that CAG is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of CAG to the average industry Current Ratio of 0.90, CAG is less able to pay its short term obligations than its industry peers. 94% of its industry peers have a better Quick Ratio.
When comparing the Debt to Equity Ratio of CAG to the average industry Debt to Equity Ratio of 0.48, CAG required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.93) VS Industry: 26% outperformed.

53.34
0.00

Quick Ratio (0.29) VS Industry: 6% outperformed.

0.01
48.00

Current Ratio (0.92) VS Industry: 17% outperformed.

0.01
49.63

Altman-Z (1.96) VS Industry: 43% outperformed.

-34.87
80.57

Dividend

Dividend Rating

5

CAG's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.42, CAG pays a bit more dividend than the S&P500 average.
On average, the dividend of CAG grows each year by 12.57%, which is quite nice.
CAG has been paying a dividend for at least 10 years, so it has a reliable track record.

CAG has a Yearly Dividend Yield of 3.48%. Purely for dividend investing, there may be better candidates out there.
The dividend of CAG is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
CAG pays out 89.25% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (3.48%) VS Industry: 65% outperformed.

0.73
17.92

CONAGRA BRANDS INC36.26

NYSE:CAG (2/7/2023, 7:04:00 PM)-0.65 (-1.76%)

After market: 36.25 -0.01 (-0.03%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 01-05 2023-01-05/bmo Earnings (Next) 04-05 2023-04-05/amc
Inst Owners 84.95% Inst Owner Change -0.61%
Ins Owners 0.44% Ins Owner Change -2.37%
Market Cap 17.28B Analysts 69.09
Price Target 42.5 (17.21%)

Dividend
Industry RankSector Rank
Dividend Yield 3.48%
Dividend Growth(5Y) 12.57% DP 89.25%
Div Incr Years 3 Div Non Decr Years 5
Ex-Date 01-27 2023-01-27 (0.33)

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 14.38%
Min EPS beat(2) 8.04% Max EPS beat(2) 20.72%
EPS beat(4) 3 Avg EPS beat(4) 7.52%
Min EPS beat(4) -0.5% Max EPS beat(4) 20.72%
Revenue beat(2) 1 Avg Revenue beat(2) 0.43%
Min Revenue beat(2) -0.09% Max Revenue beat(2) 0.95%
Revenue beat(4) 2 Avg Revenue beat(4) 0.15%
Min Revenue beat(4) -1.66% Max Revenue beat(4) 1.42%
PT rev (1m) 9.29% PT rev (3m) 14.05%
EPS NQ rev (1m) 7.8% EPS NQ rev (3m) 7.8%
EPS NY rev (1m) 0% EPS NY rev (3m) 0.47%
Revenue NQ rev (1m) 2.75% Revenue NQ rev (3m) 2.73%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.42%

Valuation
Industry RankSector Rank
PE 13.89
Fwd PE 13.73
P/S 1.44
P/FCF 21.14
P/OCF 14.25
P/B 1.99
P/tB N/A
EV/EBITDA 12.27
EPS(TTM) 2.61 EY 7.2%
EPS(NY) 2.64 Fwd EY 7.28%
FCF(TTM) 1.72 FCFY 4.73%
OCF(TTM) 2.54 OCFY 7.02%
SpS 25.26 BVpS 18.18
TBVpS -12.78 PEG (NY) 3.02
PEG (5Y) 3.49

Profitability
Industry RankSector Rank
ROA 3.04%
ROE 7.87%
ROIC 7.47%
ROICexc 7.49%
ROICexgc 33.43%
OM 14.95%
PM 5.66%
GM 25.43%
ROICexgc(3y) 43.07% ROICexcg growth 3Y 4.8%
ROICexcg growth 5Y -6.49% ROICexc(3y) 7.74%
ROICexc growth 3Y 7.81% ROICexc growth 5Y -14.82%
OM growth 3Y -0.22% OM growth 5Y -6.62%
PM growth 3Y 2.7% PM growth 5Y -1.16%
GM growth 3Y -3.86% GM growth 5Y -3.84%
F-Score 6 Asset Turnover 0.54

Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 11.5
Debt/EBITDA 4.34
Cap/Depr 107.59%
Profit Quality 119.95%
Current Ratio 0.92
Quick Ratio 0.29
Altman-Z 1.96
F-Score 6 WACC 6.62%
ROIC/WACC 5.05 Cap/Depr(3y) 116.45%
Cap/Depr(5y) 110.65% Profit Quality(3y) 109.89%
Profit Quality(5y) 106.11%

Growth
EPS 1Y 14.98% EPS 3Y 5.65%
EPS 5Y 3.98% EPS growth Q2Q 26.56%
EPS Next Y 4.6% EPS Next 2Y 5.56%
EPS Next 3Y 5.75% EPS Next 5Y 8.26%
Revenue growth 1Y 7.29% Revenue growth 3Y 6.54%
Revenue growth 5Y 8.07% Revenue growth Q2Q 8.3%
Revenue Next Year 5.49% Revenue Next 2Y 3.43%
Revenue Next 3Y 2.71% Revenue Next 5Y 3.07%
EBIT growth 1Y -2.7% EBIT growth 3Y 6.31%
EBIT growth 5Y 0.91% EBIT Next Year 33.89%
EBIT Next 3Y 12.85% EBIT Next 5Y 10.82%
FCF growth 1Y -45.07% FCF growth 3Y -2.64%
FCF growth 5Y -5.87% OCF growth 1Y -38%
OCF growth 3Y 1.51% OCF growth 5Y -0.49%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA